CYTODRIVE Trademark

Trademark Overview


On Thursday, December 8, 2022, a trademark application was filed for CYTODRIVE with the United States Patent and Trademark Office. The USPTO has given the CYTODRIVE trademark a serial number of 97708951. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, June 27, 2024. This trademark is owned by Obsidian Therapeutics, Inc.. The CYTODRIVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the field of cell and gene therapies for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders
cytodrive

General Information


Serial Number97708951
Word MarkCYTODRIVE
Filing DateThursday, December 8, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations in the field of cell and gene therapies for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameObsidian Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Party NameObsidian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events


Event DateEvent Description
Monday, December 12, 2022NEW APPLICATION ENTERED
Thursday, January 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Monday, October 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU EXTENSION 1 FILED
Thursday, June 27, 2024SOU EXTENSION 1 GRANTED